Log Type | Authored on | Log Node | Authored by |
---|---|---|---|
Newsletter sent | Tue, 11/08/2022 - 12:04 | Anonymous | |
Newsletter sent | Tue, 11/08/2022 - 12:04 | Anonymous | |
Newsletter sending | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Fri, 07/31/2020 - 07:58 | Anonymous | |
Newsletter sent | Tue, 11/08/2022 - 12:04 | Anonymous | |
Newsletter opened | Fri, 07/31/2020 - 07:15 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Fri, 07/31/2020 - 06:11 | Anonymous | |
Newsletter clicked | Fri, 07/31/2020 - 05:53 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Fri, 07/31/2020 - 02:44 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous |
Log Type | Authored on | Log Node | Authored by |
---|---|---|---|
Newsletter sent | Tue, 11/08/2022 - 12:04 | Anonymous | |
Newsletter sent | Tue, 11/08/2022 - 12:04 | Anonymous | |
Newsletter sending | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Fri, 07/31/2020 - 07:58 | Anonymous | |
Newsletter sent | Tue, 11/08/2022 - 12:04 | Anonymous | |
Newsletter opened | Fri, 07/31/2020 - 07:15 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Fri, 07/31/2020 - 06:11 | Anonymous | |
Newsletter clicked | Fri, 07/31/2020 - 05:53 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter subscribed | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous | |
Newsletter opened | Fri, 07/31/2020 - 02:44 | Anonymous | |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
Newsletter opened | Wed, 10/12/2022 - 13:23 | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonymous |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
OWA Status | Wed, 10/12/2022 - 13:23 | Anonymous | |
User created | Wed, 10/12/2022 - 13:23 | Anonymous |